These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2569321)

  • 1. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Allen RC; Epstein DL
    Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate.
    Keates EU; Stone RA
    Am J Ophthalmol; 1981 Feb; 91(2):243-8. PubMed ID: 7468740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timolol and epinephrine: long-term evaluation of concurrent administration.
    Korey MS; Hodapp E; Kass MA; Goldberg I; Gordon M; Becker B
    Arch Ophthalmol; 1982 May; 100(5):742-5. PubMed ID: 7044351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
    Dorigo MT; Cerin O; Fracasso G; Altafini R
    Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
    Brooks AM; Gillies WE
    Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
    Evans DW; Harris A; Cantor LB
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
    Krieglstein GK; Mohamed J
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):284-92. PubMed ID: 6127861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure.
    Albracht DC; LeBlanc RP; Cruz AM; Lamping KA; Siegel LI; Stern KL; Kelley EP; Stoecker JF
    Am J Ophthalmol; 1993 Sep; 116(3):307-13. PubMed ID: 8357055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E; Tipping R; Vogel R
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betaxolol vs timolol. A six-month double-blind comparison.
    Stewart RH; Kimbrough RL; Ward RL
    Arch Ophthalmol; 1986 Jan; 104(1):46-8. PubMed ID: 3510612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betaxolol.
    Goldberg I
    Aust N Z J Ophthalmol; 1989 Feb; 17(1):9-13. PubMed ID: 2569884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betaxolol and timolol. A comparison of efficacy and side effects.
    Berry DP; Van Buskirk EM; Shields MB
    Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol.
    Lynch MG; Whitson JT; Brown RH; Nguyen H; Drake MM
    Arch Ophthalmol; 1988 Jul; 106(7):908-11. PubMed ID: 2898932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.